Charis Eng, MD, PhD, received a two-year, nearly $680,000 grant from the PTEN Research Foundation to investigate how genomic alterations influence PTEN hamartoma tumor syndrome (PHTS). With this grant, Dr. Eng’s team will sequence the whole genomes of a large number of PHTS patients from around the world to understand if and how changes in non-coding regions of the genome affect clinical outcomes.
Dr. Eng is the inaugural chair of the Cleveland Clinic Genomic Medicine Institute and inaugural director of the Center for Personalized Genetic Healthcare; Professor and Vice Chair, Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine; Member, Member, Cancer Prevention Control & Population Research Program, Case Comprehensive Cancer Center.